Inflammation

Q&A: Dexamethasone and COVID-19 thumbnail image

Health & Medicine

|

Q&A

Q&A: Dexamethasone and COVID-19

According to a trial in the UK, dexamethasone is “the first drug shown to improve survival in COVID-19” patients. But what is it and what do these results tell us?

Understanding the response of our immune system’s powerful army thumbnail image

Health & Medicine

Understanding the response of our immune system’s powerful army

Our immune systems can swing from cytokine storm to immune suppression when fighting infection; understanding why could help us tackle the flu and COVID-19

The genetic mutation behind a new autoinflammatory disease thumbnail image

Health & Medicine

The genetic mutation behind a new autoinflammatory disease

Scientists have discovered a new human autoinflammatory disease that causes repeated episodes of debilitating fever and inflammation

Putting the brakes on lung disease thumbnail image

Health & Medicine

Putting the brakes on lung disease

Researchers have uncovered a molecular pathway that can be blocked to potentially prevent the destructive inflammation of chronic obstructive pulmonary disease, a major worldwide killer

Subscribe for your weekly email digest

By subscribing, you agree to our

Acknowledgement of country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities
Phone: 13 MELB (13 6352) | International: +61 3 9035 5511The University of Melbourne ABN: 84 002 705 224CRICOS Provider Code: 00116K (visa information)